Literature DB >> 16619155

Galactomannan and the diagnosis of invasive aspergillosis.

John H Rex.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16619155     DOI： 10.1086/503432

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  4 in total

1.  Diagnosis of invasive aspergillosis by a commercial real-time PCR assay for Aspergillus DNA in bronchoalveolar lavage fluid samples from high-risk patients compared to a galactomannan enzyme immunoassay.

Authors:  Riccardo Torelli; Maurizio Sanguinetti; Adrian Moody; Livio Pagano; Morena Caira; Elena De Carolis; Leonello Fuso; Gennaro De Pascale; Giuseppe Bello; Massimo Antonelli; Giovanni Fadda; Brunella Posteraro
Journal:  J Clin Microbiol       Date:  2011-10-19       Impact factor: 5.948

2.  Effect of involved Aspergillus species on galactomannan in bronchoalveolar lavage of patients with invasive aspergillosis.

Authors:  Mojtaba Taghizadeh-Armaki; Mohammad T Hedayati; Vahid Moqarabzadeh; Saham Ansari; Saeed Mahdavi Omran; Hossein Zarrinfar; Sasan Saber; Paul E Verweij; David W Denning; Seyedmojtaba Seyedmousavi
Journal:  J Med Microbiol       Date:  2017-07-12       Impact factor: 2.472

3.  Utility of PCR in diagnosis of invasive fungal infections: real-life data from a multicenter study.

Authors:  Cornelia Lass-Flörl; Wolfgang Mutschlechner; Maria Aigner; Katharina Grif; Claudia Marth; Michael Girschikofsky; Wilhelm Grander; Richard Greil; Gudrun Russ; Peter Cerkl; Mirjam Eller; Gabriele Kropshofer; Stephan Eschertzhuber; Hermann Kathrein; Stefan Schmid; Ronny Beer; Ingo Lorenz; Igor Theurl; David Nachbaur
Journal:  J Clin Microbiol       Date:  2012-12-26       Impact factor: 5.948

Review 4.  Invasive aspergillosis: epidemiology, diagnosis and management in immunocompromised patients.

Authors:  Georg Maschmeyer; Antje Haas; Oliver A Cornely
Journal:  Drugs       Date:  2007       Impact factor: 11.431
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.